| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 12/05/2007 | EP0708831B2 Cell-density enhanced protein tyrosine phosphatases |
| 12/05/2007 | CN101084240A MyD88 homodimerization inhibitors |
| 12/05/2007 | CN101084239A Truncated LHRH formulations |
| 12/05/2007 | CN101084238A Receptor selectivity lymphotoxin derivates |
| 12/05/2007 | CN101084236A Prodrugs of excitatory amino acids |
| 12/05/2007 | CN101084016A Compositions capable of facilitating penetration across a biological barrier |
| 12/05/2007 | CN101084012A Methods of treating cancer using il-21 and monoclonal antibody therapy |
| 12/05/2007 | CN101084009A Gh secretagogues and uses thereof |
| 12/05/2007 | CN101084008A Therapeutic formulations of keratinocyte growth factor |
| 12/05/2007 | CN101084007A Use of tgf-beta antagonists to limit nephrotoxicity of immunosuppressive agents |
| 12/05/2007 | CN101084006A Method and pharmaceutical composition for preventing or treating diseases associated with inflammation |
| 12/05/2007 | CN101084005A Compounds for flaviviridae treatment |
| 12/05/2007 | CN101084004A Blood pressure lowering peptides in a single enzymatic step |
| 12/05/2007 | CN101084003A Therapeutic nutrient compositions or combinations and methods of their use |
| 12/05/2007 | CN101084002A Improved apo e analogs and methods for their use |
| 12/05/2007 | CN101083999A Presbyopia treatment by lens alteration |
| 12/05/2007 | CN101083907A Compositions and methods for topical diagnostic and therapeutic transport |
| 12/05/2007 | CN101082043A Polyethylene glycol modified L-asparaginyl amine enzyme |
| 12/05/2007 | CN101081871A Protein transduction field 4-apopain fusion protein (PTD4-Apoptin) and preparation method and application thereof |
| 12/05/2007 | CN101081870A Antineoplastic biological medicament PTD4-GFP-Apoptin fusion protein and preparation method thereof |
| 12/05/2007 | CN101081869A Humanized antibodies that recognize beta amyloid peptide |
| 12/05/2007 | CN101081868A Humanized antibodies that recognize beta amyloid peptide |
| 12/05/2007 | CN101081867A Humanized antibodies that recognize beta amyloid peptide |
| 12/05/2007 | CN101081865A Abstraction of pilose antler releasing somatomedin (DEER GHRF) and preparation method thereof |
| 12/05/2007 | CN101081864A A plurality of reconstructing antibiotic peptide and preparation method and application thereof |
| 12/05/2007 | CN101081295A Antibiotic, composition containg antibiotic and method for the administration of antibiotic and said composition to livestock |
| 12/05/2007 | CN101081244A Method for the preservation of biological activity of activity polypeptides agent which is made from plants and is took orally for reducing blood suger |
| 12/05/2007 | CN101081232A Yak bone marrow glair polypeptides bone extract and the composition thereof and the preparing method |
| 12/05/2007 | CN101081215A Conotoxin SO3 nanometer grain composition and method of making the same and the application thereof |
| 12/05/2007 | CN101081212A Protease inhibitors liposomes aerosol |
| 12/05/2007 | CN101081097A Magnetic beads activity factor cream massage bra |
| 12/05/2007 | CN100352930C Vaccines immunotherapeutics and method for using the same |
| 12/05/2007 | CN100352921C Compositions and methods for identifying antigens which elicit an immune response |
| 12/05/2007 | CN100352843C Kdr peptides and vaccines comprising the same |
| 12/05/2007 | CN100352841C Antibiotic peptide and its coding sequence and uses |
| 12/05/2007 | CN100352840C Nucleus factor-kB p50 subunit combination peptide, preparation and application thereof |
| 12/05/2007 | CN100352838C Interfusion protein of antineoplastic genetic engineering composed of target short peptide of receptor of epidermal growth factor and Lidamycin |
| 12/05/2007 | CN100352837C Pegylated T1249 polypeptide |
| 12/05/2007 | CN100352836C Novel depsipeptides and process for preparing same |
| 12/05/2007 | CN100352835C Corn albumen powder polypeptide, its separation method and uses |
| 12/05/2007 | CN100352832C Oligopeptides for promoting hair growing |
| 12/05/2007 | CN100352819C Novel compounds as NS3-serine protease inhibitors of hepatitis c virus |
| 12/05/2007 | CN100352504C Nutritious supplementing agent contg. a-glucosidase inhibitor and a-amylase inhibitor |
| 12/05/2007 | CN100352503C Drug for preventing vascular restenosis and instrument to be embedded in vessel coated with the drug |
| 12/05/2007 | CN100352499C High mannose proteins and method of making mannose proteins |
| 12/05/2007 | CN100352498C Three dimensional eye patch for treating eye wrinkles an its preparation method |
| 12/05/2007 | CN100352497C Antibody inhibition body fluid immunity of using special integrated CD40CR(CD40 part) |
| 12/05/2007 | CN100352496C Lugua polypeptides for injection and its preparing process |
| 12/05/2007 | CN100352495C Stabilized pharmaceutical composition in lyophilized form |
| 12/05/2007 | CN100352494C Pharmaceutical preparation containing cyclopeptide and chemotherapeutic agent or angiogenesis inhibitor |
| 12/05/2007 | CN100352493C Method of treating tumors |
| 12/05/2007 | CN100352442C Pharmaceutical combinations |
| 12/05/2007 | CN100352427C Biodegradable microparticles for controlled release administration, with purified amylopectin-based starch of reduced molecular weight |
| 12/05/2007 | CN100352374C Satiety inducing composition |
| 12/04/2007 | US7304181 making side group protected homocysteine by reacting methionine with sodium in ammonia then alkylating the mercapto group such as with tert-butoxycarbonylalkyl protecting group; use as intermediate in synthesis cyclic peptides, particularly oxytocin antagonist peptides |
| 12/04/2007 | US7304144 Antibodies binding to human TSLP Polypeptides |
| 12/04/2007 | US7304141 Human leucine-rich repeat containing protein expressed predominately in bone marrow, HLRRBM1 |
| 12/04/2007 | US7304140 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes/pericytes/adipocytes/endothelial cells by contacting blood with polypeptide; cancer diagnosis |
| 12/04/2007 | US7304139 Polynucleotides and polypeptides of Anaplasma phagocytophilum and methods of using the same |
| 12/04/2007 | US7304138 Therapeutic and diagnostic methods and compositions based on jagged/notch proteins and nucleic acids |
| 12/04/2007 | US7304137 Nucleotide and amino acid sequences of asporins |
| 12/04/2007 | US7304129 Peptides that stimulate cell survival and axon regeneration |
| 12/04/2007 | US7304128 High affinity and specificity, separation and immobilization of these structures for the fabrication of nano-devices |
| 12/04/2007 | US7304127 Polypeptides that bind HIV gp120 and related nucleic acids, antibodies, compositions, and methods of use |
| 12/04/2007 | US7304088 Peptide like compounds for treating coronavirus or hepatitis C virus; severe acute respiratory distress syndrome |
| 12/04/2007 | US7304086 Inhibitors of glutaminyl cyclase |
| 12/04/2007 | US7304085 Nitrogen-containing heteroaryl derivatives |
| 12/04/2007 | US7304054 Dibenzodiazepinone analogues, processes for their production and their use as pharmaceuticals |
| 12/04/2007 | US7304053 Glycoprotein-mediated MDR |
| 12/04/2007 | US7304045 Nanoparticles for targeting hepatoma cells |
| 12/04/2007 | US7304040 Suppression of post-transplant arteriosclerosis |
| 12/04/2007 | US7304038 Therapeutic composition and method of supporting the immune system |
| 12/04/2007 | US7304037 Cytostatic conjugates with integrin ligands |
| 12/04/2007 | US7304035 Stimulation of bone growth with thrombin peptide derivatives |
| 12/04/2007 | US7304034 Use of HMGB fragments as anti-inflammatory agents |
| 12/04/2007 | US7304033 Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules |
| 12/04/2007 | US7304032 CD-10 activated prodrug compounds |
| 12/04/2007 | US7304031 Methods and means for producing proteins with predetermined post-translational modifications |
| 12/04/2007 | US7304030 Administering to exposed vital dental pulp tissue of mammal active enamel substance comprising enamel matrix proteins selected from enamelins, amelogenins, amelins, ameloblastin, sheathlin, tuftelins, dentinsialoprotein, dentinsialophosphoprotein to promote regeneration of secondary dentin, osteodentin |
| 12/04/2007 | US7304029 Inducing a neuroprotective effect of rescuing neurons destined to degenerate or die as a result of hypoxia or ischemia in a brain of a patient by administering growth hormone centrally to the brain of the patient |
| 12/04/2007 | US7303896 Nucleic acid encoding novel type-1 cytokine receptor GLM-R |
| 12/04/2007 | US7303895 Choline transport like (CTL) membrane proteins involved in choline transport |
| 12/04/2007 | US7303890 Proteins, genes encoding them and method of using the same |
| 12/04/2007 | US7303885 For treating or detecting MIF (macrophage migration inhibitor factor) related diseases by detecting MIF/Jab1 (c-Jun activation domain binding protein) interactions; complex MIF in natural association with Jab1 and optionally another protein |
| 12/04/2007 | US7303871 Administering glutenase to Celiac or dermatitis herpetiformis patient reduces levels of toxic gluten oligopeptides, thereby attenuating or eliminating damaging effects of gluten |
| 12/04/2007 | US7303770 Cancer chemoprotective food products |
| 12/04/2007 | US7303762 Absorption enhancers |
| 12/04/2007 | US7303748 Locally administering an effective amount of an agent capable of blocking or inhibiting vascular endothelial growth factor (VEGF)-mediated activity to a subject in need thereof, such that the eye injury is ameliorated or improved, wherein the agent is VEGFR1R2-Fc Delta C1(a) (SEQ ID NO:2) |
| 12/04/2007 | US7303747 Use of VEGF inhibitors for treatment of eye disorders |
| 12/04/2007 | US7303746 Methods of treating eye disorders with modified chimeric polypeptides |
| 12/04/2007 | US7303739 Cyclic phosph(oramid)ate prodrugs having alcohol, amine, orthiol groups attached to phosphorus; camptothecins; pharmacodynamic half-life; diagnostic imaging |
| 12/04/2007 | CA2310677C In vitro and in vivo growth-promoting proteins and peptides for kidney epithelial cells |
| 12/04/2007 | CA2283295C Concurrent in-vivo immunoconjugate binding to multiple epitopes of vascular permeability factor on tumor-associated blood vessels |
| 12/04/2007 | CA2262647C Methods for regulating gastrointestinal motility |
| 12/04/2007 | CA2201120C Polyethylene glycol modified ceramide lipids and liposome uses thereof |
| 12/04/2007 | CA2157506C Osteogenic growth oligopeptides and pharmaceutical compositions containing them |
| 12/04/2007 | CA2140878C Interleukin-4 stimulated t lymphocyte cell death |
| 11/29/2007 | WO2007137275A2 Stimulators of osteoblastogenesis and applications of the same |
| 11/29/2007 | WO2007137129A2 RNAI-MEDIATED INHIBITION OF TUMOR NECROSIS FACTOR α-RELATED CONDITIONS |
| 11/29/2007 | WO2007137015A2 Dermatological uses of tri-, tetra-, penta-, and polypeptides |